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Structure Activity Relationship Studies of Novel Diarylpentanoid Analogs
Targeting The Androgen Receptor in Prostate Cancer Cells
Haili Coffin and Dr. Marco Bisoffi
Chapman University, Schmid College of Science and Technology, Biochemistry and Molecular Biology, Orange, CA
Experimental Methods

Introduction
• Prostate cancer is the second most common cancer in
American men with an incidence and mortality of
approximately 240,000 and 30,000 men, accordingly.
• Curcumin, a natural phytochemical of the plant Curcuma
longa and an ingredient in the spice Turmeric, has been
shown to inhibit prostate cancer cell growth and has
inspired the synthesis of synthetic analogs, including a vast
number of structurally diverse diarylpentanoids.
• Prostate cancer progression relies strongly on the activation
of the androgen receptor (AR) signaling pathway by its
natural ligand dihydrotestosterone.

Conclusions

Cells: Human LNCaP prostate cancer cells were cultured at 37oC in humidified air containing 5% CO2.
Drug Treatment: Cells were seeded at 150,000 cells per well in a 12-well plate and grown for 48 hours to ~90% confluency.
Cells were treated for 16 hours with 4μM and 8μM drug final concentrations. Cells were lysed with Triton X100, spun
down, and whole cell lysate was transferred into new Eppendorf tubes.
Bradford Assay: Protein concentration was determined by Bradford reagent using BSA (bovine serum albumin) as a
standard. Absorbance was measured at 595 nm.
Western Blot & Image J analysis: Detection of AR protein expression was determined by Western blot using specific
antibodies. AR signal intensity was normalized to β-actin. Signal intensities were determined using densitometric analysis
of digitized images using ImageJ software.
Cell imaging. The dose-dependent effect of ca27 and its analogs was visualized by bright field light microscopy (transmitted
light).

Results
Western Blot Analysis

Levels of Androgen Receptor (AR) in LNCaP prostate cancer cells treated with ca27 analogs. β-Actin is used as the
control. From left to right dose dependency is shown with 4um of each compound followed by 8um.

• We hypothesized that the presence and position of the
hydroxyl groups of ca27, as well as the Michael acceptors (αβ unsaturated carbonyl) are important for AR downregulation.
• Our studies aim at identifying active pharmacophores of
diarylpentanoids that down-regulate AR expression. When
targeted to prostate cancer cells, this could lead to the
development of novel therapeutics against castration
resistant prostate cancer.
• The following diarylpentanoid compounds were used. They
differ in the length of the alkenyl space between aryl rings,
the nature and position of hydroxyl side groups, and the
presence of Michael acceptors.
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• The hydroxyl groups are stronger contributors to AR
down-regulation than the Michael acceptors.
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.
Quantification of Western blot analysis using Image J shows the numerical values of AR present in LNCaP cells after
treatment with 4um and 8um ca27 analogs. DMSO serves as a negative control and ca27 as a positive control. The
ratio’s were normalized over the housekeeping gene β-Actin.

LNCaP cells imaged using bright field microscopy to visually depict morphological
changes (toxicity, cell death) induced by the curcumin analogs.

• The observations on the AR down-regulation are
mimicked by the effects of the curcumin and ca27
analogs on cell morphology. Ca27 is the most cytotoxic
compound and induces cell death.

Future Research
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• Diarylpentanoid analogs of the natural product
curcumin (a diarylheptanoid), especially ca27, are
potent dose-dependent down-regulators of the
androgen receptor.

• The position of the hydroxyl groups is important for
the observed AR down-regulation. The ortho position
is more potent than the meta or para position.

• The curcumin analog ca27 has been previously shown to
down-regulate AR expression via an unknown mechanism
of action.
• The purpose of the present work was to conduct functional
structure activity relationship (SAR) studies for analogs of
ca27 to determine the moiety of ca27 responsible for AR
down-regulation.

Our results show that:

•
•
•

Optimize assay design to reduce variation.
Expand investigations to various cancer cell types,
including pancreatic and breast cancer cell models.
Determine the mechanism of action of the
diarylpentanoid compounds.

Significance
• AR is a therapeutic target against prostate (and
other) cancer cells.
• Diarylpentanoid analogs of curcumin may lead to
the identification of lead pharmacophores that lend
themselves to further drug design for the
chemoprevention and/or treatment of solid tumors,
including prostate cancer.
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